* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download STV(])FES O!}{(])CJ(vq POqt£/ffl1flLS
Psychedelic therapy wikipedia , lookup
Discovery and development of cephalosporins wikipedia , lookup
Zoopharmacognosy wikipedia , lookup
Pharmaceutical marketing wikipedia , lookup
Discovery and development of proton pump inhibitors wikipedia , lookup
Polysubstance dependence wikipedia , lookup
Environmental persistent pharmaceutical pollutant wikipedia , lookup
Orphan drug wikipedia , lookup
Environmental impact of pharmaceuticals and personal care products wikipedia , lookup
Discovery and development of non-nucleoside reverse-transcriptase inhibitors wikipedia , lookup
Drug design wikipedia , lookup
Discovery and development of cyclooxygenase 2 inhibitors wikipedia , lookup
Pharmacogenomics wikipedia , lookup
Neuropharmacology wikipedia , lookup
Prescription drug prices in the United States wikipedia , lookup
Prescription costs wikipedia , lookup
Pharmacokinetics wikipedia , lookup
Pharmaceutical industry wikipedia , lookup
Neuropsychopharmacology wikipedia , lookup
Psychopharmacology wikipedia , lookup
Drug interaction wikipedia , lookup
"STV(])FES O!}{(])CJ(vq POqt£/ffl1flLS" INTRODLICTION : Pharmacology (derived from Greek words. pharmacon-drug; logos-discourse in) consists of detailed study of drugs - its source. physical and chemical properties. compounding, biochemical and physiological effects. pharmacodynamics (its mechanism of action). pharmacokinetics (absorption. distribution. biotransformation and excretion), therapeutic and other uses of drugs. According to WHO definition 'Drug is any substance or product that is used or intended to be used to modify or explore physiological system or pathological states for the benefit of the recipient'. Medicinal or pharmaceutical chemistry is a scientilic discipline at the intersection of chemistry and pharmacology involved with designing, synthesizing and developing pharmaceutical drugs. Medicinal chemistry involves the identilication, synthesis and development of new chemical entities suitable for therapeutic use. It also includes the study of existing drugs, their biological properties, and their quantitative structureactivity relationships (QSAR). Pharmaceutical chemistry is focused on quality aspects of medicines and aims to assure fitness for the purpose of medicinal products. Medicinal chemistry is a highly interdisciplinary science combining organic chemistry with biochemistry, computational chemistry, pharmacology. pharmacognosy, molecular biology, statistics, and physical chemistry. Fighting disease with drugs is the timeless struggle; its begging echoed out of the primeval jungle. Man' s survival on the planet has depended upon its success. Today the conflict continues unabated in the laboratory and clinic. The scientific approach to this struggle is pharmacology. In return for the contributions of fundamental science to medicinal chemistry, the latter has given the chemical. biological and engineering science a new input in many fields. The discovery of the medicinal usefulness of a 23 compound has always stipulated inquiry into the chemical reaction and improved methods of preparation of similar substances. Chemists have created new drugs and hormones, as well as vitamins and other essential biochemicals, and have developed methods of substances available at reasonable cost. Investigations in medicinal chemistry are undertaken as an adventure of the human spirit, essentially an artistic enterprise, stimulated largely by curiosity and served disciplined imagination. Moreover. most medicinal scientists do their work for the fun of it, in spite of the uncertainty of the out come of their experiments. This uncertainty is great enough even in the most carefully planned scientific research programmes, but it becomes overpowering in medicinal chemistry. We still do not know, in a single instance, the details of the events by which a drug or metabolite exerts its biological effects. This greatly impairs prediction of the action of drugs and success in their design. This dilemma has both stimulating and sobering effects on the progress of medicinal chemistry. The need for better and more effective drug has greatly increased research on medicinal science because both scientists, and the sponsors of their work. realise that the odds of success may be proportional to the amount of work performed. As Schiller wrote "To one man science is the highest, the heaven goddess; to another it is a proficient cow that supplies him with butter". In balancing the low chances of practical clinical success in medicinal research against necessity to build up our store house of knowledge, medicinal scientists have to rely on inner strength and purposeful determination. The small club of medicinal scientists gratefully seized upon. the few prototypes of therapeutically active compounds provided by nature or by sheer chance observation. The main concern of pharmaceutical chemistry has remained the analyses and preparation of drugs. Medicinal chemistry tries to hope that biochemical rationales for drugs discovery may be found. The interpretation of drugs action at the molecular level is the intellectual goal of medicinal chemistry. It has provided professional excitement, dedication and scicntific fuel to the best of medicinal scientists. Drug use and abuse is as old as mankind itself Human beings have always had a desire to eat or drink substances that make them feel relaxed. stimulated, or euphoric. The 24 oldest records of therapeutic plants and minerals stem from the ancient Chinese, the Hindus, the South American and the Mediterranean peoples of antiquity. The earliest references about medicinal preparation in writing come from India in RIGVEDA and from China in their MATERIA MEDICA 2500 - 3000 B.C. In India later on, a large number of medicinal preparations including A YURVEDA were described by physicians such as CHARAK, SUSHRUTA, VAAGBHATT and others. Humans have used drugs of one sort or another for thousands of years. Wine was used at least from the time of the early Egyptians; narcotics from 4000 B.C.; and medicinal use of marijuana has been dated to 2737 BC in China. As time went by, "home remedies" were discovered and used to alleviate aches, pains and other ailments. Most of these preparations were herbs, roots, mushrooms or fungi. They had to be eaten, drunk, rubbed on the skin, or inhaled to achieve the desired effect. One of the oldest records of such medicinal recommendations is found in the writings of the Chinese scholar-emperor Shen Nung, who lived in 2735 BC. He compiled a book about herbs, a fore runner of the medieval pharmacopoeias that listed all the then-known medications, He was able to judge the value of some Chinese herbs. ror example, he found that Ch'ang Shan was helpful in treating fevers. Such fevers were, and still are, caused by malaria parasites. South and Central American Indians made many prehistoric discoveries of drug-bearing plants. Mexican Aztecs even recorded their propcrties in hieroglyphics on rocks, but our knowledge of their studies comes mainly from manuscripts of Spanish monks and medical men attached to the forces of the conquistador Hernan Cortes (1485-1547). Pre-Columbian Mexicans used many substances, ii'om tobacco to mind-expanding (hallucinogenic) plants, in their medicinal collections. The most fascinating of these substances are sacred mushrooms, used in religious ceremonies to induce altered states of mind, not just drunkenness. 25 These were all naturally occurring substances. No refinement had occurred. and isolation of specific compounds (drugs) had not taken place. As the centuries unrolled and new civilizations appeared. cultural. artistic. and medical developments shifted toward the new centers of power. A reversal of the traditional search for botanical drugs occurred In Greece in the fourth century Be when Hippocrates (estimated dates, 460-377 BC). the "Father of Medicine" became interested in inorganic salts as medications. Hippocrates' authority lasted throughout the Middle Ages and reminded alchemists and medical experimenters of the potential of inorganic drugs. In fact, a distant descendant of Hippocrates' prescriptions was the use of antimony salts in elixirs (alcoholic solutions) advocated by Basilius Valentius in the middle of the 15th century and by the medical alchemist Phillippus Aureolus Paracelsus (born Theophrastus Bombast von Hohenheim, in Switzerland, 1493-1541). South American Indians. especially those in the Peruvian Andes mountains, made several early discoveries of drug-bearing plants. Two of these plants contain alkaloids of worldwide importance that have become modern drugs. They are cocaine and quinine. Cocaine's potential for addiction was known and used with sinister intent by South American Indian chiefs hundreds of years ago. In sixteenth century. extracts of cinchona bark had been used against malaria and ipecacuanha roots for treatment of amebiasis. which are now-a-days. known to contain quinine and emetine respectively. The real growth of the systematic study of drugs in relation to their chemical nature had to await the isolation of pure compounds. Seturner in 1816 isolated morphine from opium, and since that time the isolation of active principles from crude drugs has proceeded until the present time and even now is being actively pursued. The only difference made by the passage of 192 years is that where the early workers concentrated themselves with isolating alkaloids from materials containing them in fair quantity present day researchers obtain very minute quantities of active compounds from materials which contain only the smallest trace as for example. isolation of Vitamin B 12. 26 a naturally occurring cobalt compound present in liver only to an extent of a milligram or so per kilogram of liver. Perhaps the most beneficial medicinal innovation of the nineteenth century was the discovery of general anesthesia. Davy (1778 - 1829) intruduced nitrous oxide (laughing gas) as an inhalation anesthetic, and this was followed by the first clinical experiments with ether in surgical amphitheater. One imp0l1ant period of development in this subject was the two decades from 1880 1890, which saw the introduction of Knorr's antipyrine (1883) and Dresser's aspirin (1899), together with the accidental discovery in 1888 of the earliest synthetic hypnotic sulphonal, although it was not until 1904 that V.Morning and E.Fischer discovered diethyl barbituric acid (Veronal). At the turn of century Stotz synthesized the first honnone Adrenaline (1904) and Burger and Dale in 1909 made a fundamental study of the eIIect of chemical structure in the series of sympathomimetic amines on the physiological effects of the compounds. One of the greatest practitioners of medicinal Chemistry, PAUL EHLRICH (1854 1915), laid the foundation of chemotherapy and dispelled the widely held view of the immunologist Bering that chemical were more toxic to the host than to pathogenic microbes. During the nineteenth century, a number of natural products were isolated and subjected to detailed investigation of their structure and pharmacological action. Some of the compounds were found to possess a definite physiological activity and later it was observed that the physiological activity of a compound is associated with a particular structural unit or group and if this structural unit or group presents in other compound the latter also becomes biologically active. Such a part of the drug which is responsible for the actual physiological activity is known as pharmacophore group. The pharmacophoric group is then somewhat modified by the commen and simple unit process to give more active compounds with low toxicity. Although there is no broad relationship between the structure and biological activity of the various groups, yet some physiological effect is often associated with a particular structure. 27 CHEMOTHERAPY: The term chemotherapy was introduced by Paul Ehrlich to indicate the treatment of microbial disease by the administration of a drug which has a lethal or inhibitory effect on the microbe responsible and was described as a "Magic bullet" which when introduced into the body, would destroy only the bacteria at which it was aimed. He also pronounced many of the current concepts of chemotherapy. A chemotherapeutic agent is defined in terms of its function rather than its origin. The science of chemotherapy rests on many disciplines, which includes, organic chemistry, natural product research, biology of the invader and host, pharmacology, toxicity and therapeutics. Prontosll (2, 4 - diaminoazobenzene - 4'-sulphanamide) introduced by Domagk in 1932 was the first chemotherapeutic agent active against bacteria. In spite of its therapeutic effects had no in vitro antibacterial activity. The chances of devising a clinically useful medicinal chemical are indeed very slim, since several restrictive conditions are super imposed, even on the best laboratory findings high potency, should have a minimum of side effects and acute toxicity and virtually no chronic toxicity. No wonder that only small number of novel drugs are introduced into clinical practice. Every kind of drug needs improvement and should be replaced by more specific agents with fewer side effects. One cannot abandon the hope of perfecting the action of existing compounds on structural modifications. The systematic research work in pharmaceutical laboratories had led to the introduction of more systematic drugs in the modern times. The synthetic work is carried out more or less along the following lines: O. Compounds are synthesized whose structures are more or less similar to naturally occurring substances. This some times produces drug whose price is much less than the naturally occurring one. O. Attempts are made to prepare the compounds with simplified structures based on the structures of natural drugs. 28 O. Attempts are made to synthesize new drug which have the properties of certain natural products, but have no relation to them in structure. O. Attempts are made to synthesize new drug which are unrelated in structure and properties to natural products. Different types of drugs generally used are designated as anesthetic, analgesic. antipyretic, antituberculostatic, antihistamine, antihypertensive, anticonvulsant, anticoagulant, Anthelmintic, antimalarial, anti leprotic, anti-inflammatory, antiallergic, antithyroid, sedative and hypnotics, etc .. which prompted us to synthesize several new Naproxen derivatives. Aims and objectives of present investigation are as under: () To generate several Naproxen derivatives bearing biologically active heteromonocycles like thiazolidinones and 5-arylidines. () To characterize these products for their structural assignment uSll1g elemental analysis and various spectroscopic techniques like IR and NMR. () To study, the structure - activity relationship and screen these new derivatives for their antibacterial, antifungal, antitubercular, analgesic and antiinflammatory activities. 29 In the present thesis, it is our modest effort to devise some new organic compounds containing NAPROXEN moiety, an analgesic and anti-inflammatory agent. The following types of the compounds have been prepared and tested for their antimicrobial activities and anti-intlammatory, analgesic activities using in vivo method. The spectroscopic analysis, elemental analysis and physical properties of the compounds have been studied. 1. PART - I : 4-0XO-THIAZOLIDINES 2. PART - II : 5-ARYLIDINES 3. PART - III: FORMAZANS 4. PART - Ill: BIOLOGICAL ACTIVITY, QSAR AND CHARACTERISATION DATA 3. I:-.ITRODUCTION TO DRUG: NAPROXEN Naproxen (INN) (pronounced) is a non-steroidal anti-inflammatory drug (NSAID) commonly used for the reduction of moderate to severe pain, fever, inflammation and stiffness caused by conditions such as osteoarthritis, rheumatoid arthritis, psoriatic arthritis, gout, ankylosing spondylitis, menstrual cramps, tendinitis, bursitis, and the treatment of primary dysmenonhea. It works by inhibiting both the COX-I and COX-2 enzymes. I Only the (S) stereoisomer of naproxen has the desired antiimflammatory activity and is safe to use. The (R) stereoisomer is reported to be a liver toxin. Since it is much more expensive to manufacture enantiomerically pure compounds, there is the potential for counterfeit supplies to enter the market which are not enantiomerically pure. In other words, the compounds would contain some mixture of two enantiomers (R & S) instead of being 100 % of the (S) stereoisomer. 2 30 1. CHEMICAL NAME: 3 (c) 2-Naphthalene acetic acid. 6-methoxy-a-methyl-.(S)-. (c) (S)-6-Methoxy-a-methyl-2-naphthalene acetic acid 2. STRllCTURAL FORMULA: 3 COOH 4. MOLECULAR WEIGHT: 3 230.26 5. ELEMENTAL COMPOSION: 3 C = 73.03% H=6.13% 0=20.84% 6. PHYSICAL PROPERTIES: 3 (d) Melting Point: The melting point ofNaproxen is 156 ± iJc (d) Form. Colour. Odour: Naproxcn occurs as a white or almost white crystal with characteristic odor. (d) Solubility: Being highly hydrophobic Naproxen is practically insoluble in water. 31 It is readily soluble in many organic solvents. Soluble in ethanol (96%) and in methanol Freely soluble in chloroform (d) Dissociation constant (pKa) : pKa = 4.2 7. PHARMACOLOGy:4 Naproxen is a member of the arylacctic acid group of nonsteroidal anti-inflammatory drugs (NSAIDs). Naproxen has analgesic and antipyretic properties. As with other NSAIDs, its mode of action is not fully understood; however, its ability to inhibit prostaglandin synthesis may be involved in the anti-inflammatory effect. Mechanism of action: 4 The mechanism of action of naproxen, like that of other NSAIDs, is believed to be associated with the inhibition of cyclooxygenase activity. Two unique cyclooxygenases have been described in mammals. The constitutive cyclooxygenase, COX-I. synthesizes prostaglandins necessary for normal gastrointestinal and renal function. The inducible cyclooxygenase, COX-2, generates prostaglandins involved in inflammation. Inhibition of COX- I is thought to be associated with gastrointestinal and renal toxicity while inhibition of COX-2 provides anti-inflammatory activity. Therapeutic Indications: 4 Naproxen is indicated for the treatment of juvenile rheumatoid arthritis, rheuma~oid arthritis, ankylosing spondylitis, osteoarthrosis, acute gout, and acute musculoskeletal disorders (for example sprains and strains, tenosynovitis, fibrositis, lumbosacral pain, direct trauma, and cervical spondylitis), and dysmenorrhoea. 32 Adverse reactions:; 1% to 10%: Cardiovascular: Edema (3% to 9%), palpitation «3%) Central nervous system: Dizziness (3% to 9%), drowsiness (3% to 9%), headache (3% to 9%), lightheadedness «3%), vertigo «3%) Dermatologic: Pruritus (3% to 9%), skin eruption (3% to 9%) purpura «3%), rash Endocrine & metabolic: Fluid retention (3% to 9%) Gastrointestinal: Abdominal pain (3% to 9%), constipation (3% to 9%), nausea (3% to 9%), heartburn (3% to 9%), diarrhea «3%), dyspepsia «3%), stomatitis «3%), flatulence, gross bleeding/perforation, indigestion, ulcers, vomiting Genitourinary: Abnormal renal function Hematologic: Hemolysis (3% to 9%), ecchymosis (3% to 9%), anemia, bleeding time increased Hepatic: LFTs increased Ocular: Visual disturbances «3%) Otic: Tinnitus (3% to 9%), hearing disturbances «3%) Respiratory: Dyspnea (3% to 9%) Miscellaneous: Diaphoresis «3%), thirst «3%) <I %: Agranulocytosis, alopecia, anaphylactic/anaphylactoid reaction, angioneurotic edema, arrhythmia, aseptic meningitis, asthma, blurred vision, cognitive dysfunction, colitis, coma, confusion, CHF, conjunctivitis, cystitis, depression, dream abnormalities, dysuria, eosinophilia, eosinophilic pneumonitis, erythema multi forme, exfoliative dermatitis, glossitis, granulocytopenia, hallucinations, hematemesis, hepatitis, hyper/hypoglycemia, hyper-/hypotension, infection, interstitial nephritis, melena, jaundice, leukopenia, liver failure, lymphadenopathy, menstrual disorders, malaise, MI, muscle weakness, myalgia, oliguria, pancreatitis, pancytopenia, paresthesia, photosensitivity, pneumonia, polyuria, proteinuria, pyrexia, rectal bleeding, renal failure, renal papillary necrosis, respiratory depression, sepsis, Stevens-Johnson syndrome, tachycardia, seizure, syncope, thrombocytopenia, toxic epidermalnccrolysis ulcerative stomatitis, vasculitis 33 Drug Interaction:' Naproxen is associated with several suspected or probable interactions that affect the action of other drugs. The following examples are the most common suspected interactions. Naproxen may increase the blood levels of lithium (Eskalith) by reducing the excretion oflithium by the kidneys. Increased levels of lithium may lead to lithium toxicity. Naproxen may reduce the blood pressure lowering effects of blood pressure medications. This may occur because prostaglandins playa role in the regulation of blood pressure. When naproxen is used in combination with aminoglycosides (e.g., gentamicin) the blood levels of the amino glycoside may increase, presumably because the elimination of aminoglycosides from the body is reduced. This may lead to more amino glycosiderelated side effects. Individuals taking oral blood thinners or anticoagulants (e.g .. warfarin) should avoid naproxen because naproxen also thins the blood, and excessi ve blood thinning may lead to bleeding. Con traindica tions:' Naproxen is contraindicated in patients with known hypersensitivity. active peptic ulcer, moderate to severe hepatic disease and infants. LD50 (mg/kg): The oral LD50 of the drug is 500 mg/kg in rats, 1200 mg/kg in mice. 4000 mg/kg in hamsters and greater than 1000 mg/kg in dogs. 34 8. PHARMACOKINETICS: Absorption: 6 The absorption of naproxen in a new controlled-release (CR) formulation (1000 mg tablet) was studied in fasting and postprandial volunteers. The total area under the plasma concentration-time curve averaged 2221 micrograms.hr/mL in fasting participants and 2111 micrograms.hr/mL in postprandial participants; whereas the difference was statistically significant (P = .025), the 95% confidence intervals indicated equivalent values. The peak plasma concentration was lower in the fasting state (63.1 micrograms/mL) than in the fed state (86.1 micrograms/mL) (P = .0001). There were no statistically significant differences between fasting versus postprandial values for the mean absorption time (9.7 hr vs. 7.7 hr) or plasma half-life (17.3 hr vs. 17.6 hr). Hence, the rate and extent of absorption of CR naproxen was not substantially altered by the ingestionoffood. Distribution:' Naproxen has a volume of distribution of 0.16 Llkg. At therapeutic levels naproxen is greater than 99% albumin-bound. At doses of naproxen greater than 500 mg/day there is less than proportional increase in plasma levels due to an increase in clearance caused by saturation of plasma protein binding at higher doses (average trough Css 36.5, 49.2 and 56.4 mg/L with 500, 1000 and 1500 mg daily doses of naproxen. respectively). The naproxen anion has been found in the milk of lactating women at a concentration equivalent to approximately 1% of maximum naproxen concentration in plasma Metabolism: ' Naproxen is extensively metabolized in the liver to 6-0-desmethyl naproxen, and both parent and metabolites do not induce metabolizing enzymes. Both naproxen and 6-0desmethyl naproxen are further metabolized to their respective acylglucuronide conjugated metabolites. 35 Excretion: 7 The clearance of naproxen is 0.13 mL/min/kg. Approximately 95% of the naproxen from any dose is excreted in the urine, primarily as naproxen « 1%). 6-0-desmethyl naproxen « 1%) or their conjugates (66% to 92%). The plasma half-life of the naproxen anion in humans ranges from 12 to 17 hours. The corresponding half-lives of both naproxen's metabolites and conjugates are shorter than 12 hours, and their rates of excretion have been found to coincide closely with the rate of naproxen disappearance from the plasma. Small amounts, 3% or less of the administered dose. arc excreted in the feces. In patients. with renal failure metabolites may accllmulate. Half _ Life: 7 Plasma half - life ofNaproxen is in the range 12 - 17 hours. 36 TABLE 1 PHARMACOKINETICS PARAMETERS OF NAPROXEN PARAMETRS VALUE TIME TO PEAK LEVELS 2-4 HALF LIFE (hrs) 12 - 17 ANALGESIC ACTIVITY Onset (hrs) 0.5 Duration (hrs) 8 - 12 VOLUME OF DISTRIBUTION 0.16 LlKg METABOLISM Approximately 28% of 4 dose 9. ADMINISTRATION AND DOSE For analgesia or antipyresis in adults: The recommended dose of naproxen is 220 mg every 8 - 12 hr as needed. The maximum daily dose is 660 mg. For rheumatoid arthritis dose in adults: Naproxen sodium to a maximum of 1100 mg (divided dose every 8 - 12 hr) Naproxen sodium is not recommended for less than 12 years of age. 37 TABLE-2 DOSE LIMITS Antirhcmatic Analgesic I Antipyretic 1.1 gms I day 0.66 gms I day Infants ( up to 1 year) Not recommended Not recommended Children ( 1 - 12 years) Not recommended Not recommended Adults I Adolescent Pediatric 10. STORAGE CONDITIONS AND SHELF LIFE: Always keep the naproxen in the same container it came 111. Make sure it is tightly closed. and alit of reach of children. Store this medication at room temperatllre and away from excess heat and moisture: do not store this medication in the bathroom. 38 TABLE-3 PROPREITORY PRODUCTS No 1 Dosage Form Tablet (2S0mg) Name of product manufacturer Artagen Ranbaxy Movibon Brown & Burk Naprosyn RPG Life science 2 Tablet (SOOmg) Naprosyn RPG Life science 3 Tablet (27Smg) Xenobid Rallis 4 Tablet (7S0mg) Xenar-cr Elder (a) Melting Point: The melting point of the drug power was estimated. The melting point = 1S6 ± 2 °c (b) Identification: The identity of Naproxen sample was established by taking the I.R. of the sample and I.R. was compared with that given in pharmacopeia. 39